Immunodeficiency Overview

Primary Care - Clinics in Office Practice

Volumn 35, Issue 1, 2008, Pages 159-173

  Morimoto, Yoshikazu ^a   Routes, John M ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CORTICOSTEROID; COTRIMOXAZOLE; IMMUNOGLOBULIN; INFLIXIMAB; PEGADEMASE;

ANTIMICROBIAL THERAPY; BONE MARROW TRANSPLANTATION; CHRONIC GRANULOMATOUS DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; ENZYME REPLACEMENT; HUMAN; HYPER IGM SYNDROME; IMMUNOGLOBULIN A DEFICIENCY; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; STEM CELL TRANSPLANTATION;

COMMON VARIABLE IMMUNODEFICIENCY; HUMANS; IGA DEFICIENCY; IMMUNOLOGIC DEFICIENCY SYNDROMES;

EID: 38149097942     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2007.09.004     Document Type: Review

References (63)

1. De Santis W., Esposito A., Conti V., et al. [Health care and infective aspects in patients affected by common variable immunodeficiency assisted in the Lazio Regional Authority Reference Centre for Primary Immunodeficiencies]. Infez Med 14 1 (2006) 13-23
2. Buckley R.H. Primary immunodeficiency or not? Making the correct diagnosis. J Allergy Clin Immunol 117 4 (2006) 756-758
3. Bruton O.C. Agammaglobulinemia. Pediatrics 9 6 (1952) 722-728
4. Notarangelo L., Casanova J.L., Conley M.E., et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 117 4 (2006) 883-896
5. Bonilla F.A., Bernstein I.L., Khan D.A., et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94 5 Suppl 1 (2005) S1-S63
6. Cunningham-Rundles C., and Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92 1 (1999) 34-48
7. Winkelstein J.A., Marino M.C., Ochs H., et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 82 6 (2003) 373-384
8. Folz R.J., and Routes J.M. Pulmonary Complications of Organ Transplantation and Primary Immunodeficiencies. In: Mason R.J., Murray J.F., Broaddus V.C., et al. (Eds). Textbook of respiratory medicine. 4th edition (2005), Elsevier Inc., Philadelphia 2163-2199
9. Al-Herz W., and McGeady S.J. Antibody response in common variable immunodeficiency. Ann Allergy Asthma Immunol 90 2 (2003) 244-247
10. Cunningham-Rundles C. Immune deficiency: office evaluation and treatment. Allergy Asthma Proc 24 6 (2003) 409-415
11. Padeh Y.C., Rubinstein A., and Shliozberg J. Common variable immunodeficiency and testing for HIV-1. N Engl J Med 353 10 (2005) 1074-1075
12. Knight A.K., Bingemann T., Cole L., et al. Frequent false positive beta human chorionic gonadotropin tests in immunoglobulin A deficiency. Clin Exp Immunol 141 2 (2005) 333-337
13. Buckley R.H. Pulmonary complications of primary immunodeficiencies. Paediatr Respir Rev 5 Suppl A (2004) S225-S233
14. Grunebaum E., Mazzolari E., Porta F., et al. Bone marrow transplantation for severe combined immune deficiency. JAMA 295 5 (2006) 508-518
15. Simon H.U., and Spath P.J. IVIG: mechanisms of action. Allergy 58 7 (2003) 543-552
16. Pourpak Z., Aghamohammadi A., Sedighipour L., et al. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. J Microbiol Immunol Infect 39 2 (2006) 114-120
17. Busse P.J., Razvi S., and Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 109 6 (2002) 1001-1004
18. Radinsky S., and Bonagura V.R. Subcutaneous immunoglobulin infusion as an alternative to intravenous immunoglobulin. J Allergy Clin Immunol 112 3 (2003) 630-633
19. Eijkhout H.W., van den Broek P.J., and van der Meer J.W. Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy. Neth J Med 61 6 (2003) 213-217
20. Hershfield M.S., Buckley R.H., Greenberg M.L., et al. Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N Engl J Med 316 10 (1987) 589-596
21. Booth C., Hershfield M., Notarangelo L., et al. Management options for adenosine deaminase deficiency: proceedings of the EBMT satellite workshop (Hamburg, March 2006). Clin Immunol 123 2 (2007) 139-147
22. Aiuti A., Slavin S., Aker M., et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296 5577 (2002) 2410-2413
23. Ott M.G., Schmidt M., Schwarzwaelder K., et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12 4 (2006) 401-409
24. Hacein-Bey-Abina S., Le Deist F., Carlier F., et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346 16 (2002) 1185-1193
25. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302 5644 (2003) 415-419
26. Marciano B.E., Wesley R., De Carlo E.S., et al. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 39 5 (2004) 692-699
27. Markert M.L., Devlin B.H., Alexieff M.J., et al. Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood 109 10 (2007) 4539-4547
28. Santaella M.L., Peredo R., and Disdier O.M. IgA deficiency: clinical correlates with IgG subclass and mannan-binding lectin deficiencies. P R Health Sci J 24 2 (2005) 107-110
29. Latiff A.H., and Kerr M.A. The clinical significance of immunoglobulin A deficiency. Ann Clin Biochem 44 Pt 2 (2007) 131-139
30. Litzman J., Vlkova M., Pikulova Z., et al. T and B lymphocyte subpopulations and activation/differentiation markers in patients with selective IgA deficiency. Clin Exp Immunol 147 2 (2007) 249-254
31. Detkova D., de Gracia J., Lopes-da-Silva S., et al. Common variable immunodeficiency: association between memory B Cells and lung diseases. Chest 131 (2007) 1883-1889
32. Ko J., Radigan L., and Cunningham-Rundles C. Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol 116 1 (2005) 37-41
33. Viallard J.F., Blanco P., Andre M., et al. CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation. Clin Immunol 119 1 (2006) 51-58
34. Cunningham-Rundles C., and Radigan L. Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clin Immunol 115 2 (2005) 147-153
35. Kalha I., and Sellin J.H. Common variable immunodeficiency and the gastrointestinal tract. Curr Gastroenterol Rep 6 5 (2004) 377-383
36. Warnatz K., Bossaller L., Salzer U., et al. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 107 8 (2006) 3045-3052
37. Salzer U., Maul-Pavicic A., Cunningham-Rundles C., et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 113 3 (2004) 234-240
38. Schaffer A.A., Salzer U., Hammarstrom L., et al. Deconstructing common variable immunodeficiency by genetic analysis. Curr Opin Genet Dev 17 3 (2007) 201-212
39. Salzer U., and Grimbacher B. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency. Curr Opin Allergy Clin Immunol 5 6 (2005) 496-503
40. Losi C.G., Silini A., Fiorini C., et al. Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency. J Clin Immunol 25 5 (2005) 496-502
41. Weiler C.R., and Bankers-Fulbright J.L. Common variable immunodeficiency: test indications and interpretations. Mayo Clin Proc 80 9 (2005) 1187-1200
42. Blanco-Quiros A., Solis-Sanchez P., Garrote-Adrados J.A., et al. Common variable immunodeficiency. Old questions are getting clearer. Allergol Immunopathol (Madr) 34 6 (2006) 263-275
43. Bates C.A., Ellison M.C., Lynch D.A., et al. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 114 2 (2004) 415-421
44. Aghamohammadi A., Pouladi N., Parvaneh N., et al. Mortality and morbidity in common variable immunodeficiency. J Trop Pediatr 53 1 (2007) 32-38
45. Martinez Garcia M.A., de Rojas M.D., Nauffal Manzur M.D., et al. Respiratory disorders in common variable immunodeficiency. Respir Med 95 3 (2001) 191-195
46. Thickett K.M., Kumararatne D.S., Banerjee A.K., et al. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM 95 10 (2002) 655-662
47. Kainulainen L., Varpula M., Liippo K., et al. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 104 5 (1999) 1031-1036
48. de Gracia J., Vendrell M., Alvarez A., et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immunopharmacol 4 6 (2004) 745-753
49. Knight A.K., and Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 5 2 (2006) 156-159
50. Busse P.J., Farzan S., and Cunningham-Rundles C. Pulmonary complications of common variable immunodeficiency. Ann Allergy Asthma Immunol 98 1 (2007) 1-8 quiz 8-11, 43
51. Wheat W.H., Cool C.D., Morimoto Y., et al. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 202 4 (2005) 479-484
52. Khodadad A., Aghamohammadi A., Parvaneh N., et al. Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci 52 11 (2007) 2977-2982
53. Giannouli S., Anagnostou D., Soliotis F., et al. Autoimmune manifestations in common variable immunodeficiency. Clin Rheumatol 23 5 (2004) 449-452
54. Brandt D., and Gershwin M.E. Common variable immune deficiency and autoimmunity. Autoimmun Rev 5 7 (2006) 465-470
55. Sewell W.A., Buckland M., and Jolles S.R. Therapeutic strategies in common variable immunodeficiency. Drugs 63 13 (2003) 1359-1371
56. Favre O., Leimgruber A., Nicole A., et al. Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency. Allergy 60 3 (2005) 385-390
57. El-Shanawany T.M., Williams P.E., and Jolles S. Response of refractory ITP in a patient with common variable immunodeficiency (CVID) to treatment with rituximab. J Clin Pathol 60 (2007) 715-5
58. Mahevas M., Le Page L., Salle V., et al. Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency. Am J Hematol 81 8 (2006) 645-646
59. Mullighan C.G., Fanning G.C., Chapel H.M., et al. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 159 12 (1997) 6236-6241
60. Thatayatikom A., Thatayatikom S., and White A.J. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 95 3 (2005) 293-300
61. Hatab A.Z., and Ballas Z.K. Caseating granulomatous disease in common variable immunodeficiency treated with infliximab. J Allergy Clin Immunol 116 5 (2005) 1161-1162
62. Lin J.H., Liebhaber M., Roberts R.L., et al. Etanercept treatment of cutaneous granulomas in common variable immunodeficiency. J Allergy Clin Immunol 117 4 (2006) 878-882
63. Morimoto Y., and Routes J.M. Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep 5 5 (2005) 370-375